This inventor holds 1 USPTO granted patent. Top assignee: Naegis Pharmaceuticals Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Erin Debruin: Innovator in Leukotriene Synthesis Inhibitors
Introduction
Erin Debruin is a notable inventor based in Coquitlam, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of leukotriene synthesis inhibitors. His work focuses on providing specific compounds that can be used in treating inflammatory diseases and conditions.
Latest Patents
Erin holds 1 patent for his innovative work on leukotriene synthesis inhibitors. This patent includes specific compounds and pharmaceutical compositions that utilize these compounds for therapeutic purposes. The methods outlined in his patent aim to improve treatment options for patients suffering from various inflammatory conditions.
Career Highlights
Throughout his career, Erin has been associated with Naegis Pharmaceuticals Inc., where he has contributed to the advancement of pharmaceutical research and development. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.
Collaborations
Erin has worked alongside talented colleagues, including David L Burgoyne and Julia Fonarev. Their collaborative efforts have further enhanced the research and development initiatives at Naegis Pharmaceuticals Inc.
Conclusion
Erin Debruin's innovative work in leukotriene synthesis inhibitors showcases his commitment to improving healthcare through scientific advancements. His contributions are paving the way for new treatment options in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile